Search

everythinglearnresearchcommunity

for

Search:↓

Hair loss in women linked to higher sexual dysfunction risk.

The chapter explains the causes of excessive hair growth and masculinization in women and how to measure hormone levels related to these conditions.

Men and women experience skin aging differently due to changes in sex hormone levels with age.

Male hormones may play a role in the development of heart disease, and more research is needed to understand their effects.

Lifestyle changes can improve body composition, excess male hormone levels, and insulin resistance in women with PCOS.

The document concludes that using LC-MS/MS for measuring androgens is more accurate than older methods, but it needs careful validation and standardized references to be most effective.

Androgen replacement therapy can improve libido and mood in women with severe androgen deficiency, but more research is needed on its long-term safety.

PSA can help diagnose high androgen levels in women.

The document explains how male reproductive hormones work and affect the body.

The Rotterdam Study found risk factors for elderly diseases, links between lifestyle and genetics with health conditions, and aimed to explore new areas like DNA methylation and sensory input effects on brain function.

Understanding how DHT works is important for diagnosing and treating hormone-related disorders.

Women with moderate body hair have higher levels of certain hormones and may benefit from treatment that increases sex hormone-binding protein.

FAI values above 6.4 may suggest high androgen levels and increased metabolic risks in Chinese women of reproductive age.

Different drugs can treat high male hormone levels in women, but they have various effects and some may harm a fetus.

Rosuvastatin improves lipid levels, reduces inflammation, but worsens insulin sensitivity in men with early-onset hair loss.

Hormonal therapies are effective for managing hair and skin symptoms in women with PCOS.

The 2003 consensus updated PCOS diagnosis criteria and highlighted increased risks of diabetes and heart disease for those affected.

The 2003 consensus updated PCOS diagnosis criteria and linked PCOS to higher risks of diabetes and heart problems, recommending lifestyle changes to lower these risks.

Most women with excess male hormones have Polycystic Ovary Syndrome, and hormonal therapy can improve symptoms but may cause side effects.

Diagnosing PCOS in teenagers is challenging and should use strict criteria to avoid misdiagnosis and unnecessary worry.

The conclusion is that PCOS is caused by ovarian sensitivity to hormones and disrupted hormone control, possibly due to ovarian factors, and more research is needed.

Doctors need to be better prepared to assess and treat obesity in patients.

Oxidative stress is a key factor in the development of Polycystic Ovary Syndrome, and weight management can improve symptoms.

PCOS symptoms change with age; younger women have higher androgen levels and less metabolic issues, while older women face more metabolic challenges despite milder PCOS symptoms.

Oral contraceptives help treat hyperandrogenic disorders, improving symptoms like excessive hair and acne.

Polycystic Ovary Syndrome is common but often undiagnosed, and early treatment is important to prevent health problems.

The document suggests that clinical trials for PCOS should focus on meaningful primary outcomes like live birth rates, rather than less reliable surrogate markers.

Men with male pattern baldness have a higher risk of dying from prostate cancer.

Hair loss in women can be slowed with treatment, but more research needed for better solutions.

Obesity may contribute to female hair loss by increasing male hormone levels that affect hair follicles.